DSM has reported what it describes as a “very strong” first quarter, with sales up 13% to €2,159m, with 9% organic growth. Adjusted EBITDA was up 17% to €345m and net was profit up 75% to €149m.

DSM has reported what it describes as a “very strong” first quarter, with sales up 13% to €2,159m, with 9% organic growth. Adjusted EBITDA was up 17% to €345m and net was profit up 75% to €149m. The company maintained its outlook to deliver high-single digit percentage Adjusted EBITDA growth and high double-digit basis point ROCE growth in line with the targets set out in its Strategy 2018.

"We are pleased to report a very good start to the year, with continued positive momentum in all businesses as we execute on our mid-term strategic and financial ambitions,” said Feike Sijbesma, CEO/Chairman of the DSM Managing Board. “Nutrition continued to deliver on its objectives with good growth from Animal and Human Nutrition. Materials demonstrated once again the benefit of its focus on specialties. Both businesses achieved strong volume growth, well above the market.”

“Notwithstanding the current global socio-economic volatility, we are confident that we will be able to deliver against our full-year objectives given our focus on improving our financial performance through our growth initiatives and our extensive and ambitious profit improvement programs. At the same time we continue to manage our business for the longer term by pursuing our innovation-driven growth strategy.”